Search the Newsreel

Soligenix Releases Q2 2026 Financial Results

Soligenix, Inc. reported a Q2 2026 loss per share of $0.12 and a net loss of $2.0M, representing an 85.4% improvement from the previous year. This progress in narrowing its operating deficit, coupled with positive analyst outlooks, reflects growing confidence in the biopharmaceutical company's …

A. G. P. Maintains Soligenix(SNGX.US) With Buy Rating, Maintains Target Price $1.5

A. G. P. has reiterated its Buy rating for Soligenix (SNGX.US) and maintained a target price of $1.5. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Soligenix Inc (SNGX) Earnings Forecast: Future EPS & Revenue Growth Estimates

SOLIGENIX, INC. SEC Filing (Aug 3, 2026)

This article reports on an SEC filing (Form ARS) by SOLIGENIX, INC. (SNGX) on August 3, 2026, which was accepted by the SEC EDGAR system. It notes the filing's low impact and neutral sentiment, providing links to the full PDF document and the original …

SNGX|Soligenix Inc|Price:0.374|Chg%:-0.001

This article provides a detailed profile of Soligenix Inc (SNGX), a late-stage biopharmaceutical company focused on developing products for rare diseases. It outlines the company's segments, including Specialized Biotherapeutics and Public Health Solutions, and lists key executives and shareholding information. The report also mentions …

Soligenix Inc (SNGX) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Soligenix Inc (SNGX), noting its current score of 2.27 and ranking within the Biotechnology & Medical Research industry. It details the company's beta of 1.79, indicating higher volatility compared to the S&P 500, and presents various risk …

Soligenix Inc (SNGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Soligenix Inc (SNGX), detailing its price momentum, support and resistance levels, and various technical indicators. It notes that SNGX's price momentum score is 3.70 and that the stock is currently trading between resistance at $0.40 and support …

Soligenix (SNGX) Stock Forecast & Analyst Ratings

This article provides a stock forecast and analyst ratings for Soligenix (SNGX). It includes details about the company's financial performance, recent developments, and expert opinions on its future stock price movements. Investors can use this information to assess SNGX's potential.

Soligenix Inc (SNGX) Cash Flow

This article provides a detailed cash flow statement for Soligenix Inc (SNGX), covering quarterly and annual data for operating, investing, and financing activities. It presents historical financial figures and year-over-year changes across various cash flow components. The article also includes a FAQ section explaining …

Soligenix Inc (SNGX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the major shareholders and institutional holdings of Soligenix Inc (SNGX). It lists key shareholders, their proportion of shares, and categorizes shareholder types. The report also provides quarterly institutional shareholding data and recent shareholder activity with changes in holdings for various entities.

Soligenix Inc (SNGX) Institutional Confidence

This article provides an overview of Soligenix Inc.'s (SNGX) institutional confidence, highlighting its TradingKey Stock Score and institutional shareholder activity. The data shows key institutional holders, their share counts, and the percentage change in their holdings, with Intracoastal Capital, L.L.C., and DRW Securities, LLC …

SNGX|Soligenix Inc|Price:0.371|Chg%:-0.002

Soligenix Inc (SNGX) is trading at $0.371, reflecting a slight decrease of 0.41%. Despite recent market performance, its fundamentals are considered healthy with high growth potential, and it is currently rated as "Buy" by analysts with a target price of $1.75. The company specializes …

Soligenix, Inc. Revenue Breakdown – NASDAQ:SNGX

This article provides financial information for Soligenix, Inc. (NASDAQ: SNGX) available on TradingView. It highlights that the market was closed with no trades and points to various financial data points like overview, statements, statistics, dividends, and earnings. The article also mentions top segments and …

Soligenix Inc (SNGX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Soligenix Inc (SNGX), noting its current valuation score of 6.65, which ranks 310 out of 386 in the Biotechnology & Medical Research industry. The company's P/E ratio is -0.26, and other key financial metrics like P/B, P/S, …

Soligenix Inc. (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Continued Pipeline Progress - Profit Inflection Point